Ignite Creation Date:
2024-05-05 @ 4:37 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00283114
Status:
COMPLETED
Last Update Posted:
2014-12-18
First Post:
2006-01-25
Brief Title:
A Safety Study of Lintuzumab in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome
Sponsor:
Seagen Inc
Organization:
Seagen Inc
Organization Data
Organization:
Seagen Inc
Class:
INDUSTRY
Study ID:
SG033-0001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Seagen Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None